Avid Bioservices Inc (CDMO): I just think since we have 4 KOL's added...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	85
Posts	12714
Boards Moderated	0
Alias Born	10/12/2010

biopharm

Re: horselover45 post# 158276

Monday, 01/27/2014 10:53:45 PM

Monday, January 27, 2014 10:53:45 PM

I just think since we have 4 KOL's added Dec 10, one being Dimitry Gabrilovich with "Wistar Institute", the same Wistar that is hosting:

Shigekazu Nagata, Ph.D.: "Exposure of phosphatidyleserine and engulfment of apoptotic cells"

Friday, March 21, 2014 - 10:00am

Joseph N. Grossman, M.D. Auditorium
The Wistar Institute
3601 Spruce Street
Philadelphia, Pennsylvania 19104

Shigekazu Nagata, Ph.D., professor of medicinal chemistry at Kyoto University, will be presenting this lecture.

Free and open to the public. For more information, call 215-898-3944.

http://www.wistar.org/events/2014/03/shigekazu-nagata-phd-exposure-phosphatidyleserine-and-engulfment-apoptotic-cells

IFU: I agree that Shigekazu Nagata has written/published re: PS prior, but not presented in this fashion....with a title that just stands out--- also from Japan to PA. Too many coincidences lining up. I also never seen him "presenting a lecture" such as this on attractive PS title: "Exposure of phosphatidyleserine and engulfment of apoptotic cells"

I like it...and time will tell.

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!